Tuesday, July 29, 2014

DMEMEDS shared post via Reuters: FDA Oks expanded use of Regeneron's eye drug

(Reuters) - Regeneron Pharmaceuticals Inc said the U.S. Food and Drug Administration has approved the expanded use of its eye drug Eylea for the treatment of diabetic macular edema. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/HJxo4hlM-7o/story01.htm

Read More

No comments:

Post a Comment

Subscribe Now: Feed Icon